Cardiac action potentials show up everywhere in Q-banks because they’re one of the cleanest bridges between ion channels → ECG → drugs → clinical outcomes. The trick is that most missed questions aren’t from forgetting the “phases,” but from not knowing what each phase means clinically—and how tempting distractors map to the wrong cell type, wrong ion current, or wrong ECG interval.
Tag: Cardiovascular > Cardiac Physiology
The vignette (Q-bank style)
A 67-year-old man with hypertension and stable angina is started on a new medication to reduce myocardial oxygen demand. Two days later, he develops fatigue and lightheadedness. Vitals show HR 44/min and BP 118/70 mm Hg. ECG shows sinus bradycardia without AV block.
The medication most likely decreases the slope of phase 4 depolarization in the SA node by reducing which current?
A. Fast inward sodium current ()
B. L-type calcium current ()
C. Funny current ()
D. Rapid delayed rectifier potassium current ()
E. Inward rectifier potassium current ()
Correct answer: C. Funny current ()
This patient likely started a beta-blocker (classic for stable angina) or possibly ivabradine (selectively slows SA node). Either way, the mechanism that best matches slowing the SA node rate is a decrease in the slope of phase 4 in pacemaker cells.
Why is the money current
- Pacemaker cells (SA/AV node) have an unstable resting potential.
- Their spontaneous depolarization (phase 4) is driven primarily by:
- Funny sodium current () through HCN channels
- Plus some contribution from T-type Ca channels late in phase 4
- Sympathetic stimulation (β1) increases cAMP → increases → steeper phase 4 → faster HR
- Parasympathetic stimulation (M2) decreases cAMP and opens K channels → decreases and hyperpolarizes → slower HR
Drug tie-in (high-yield)
- Beta-blockers: decrease cAMP in nodal tissue → ↓ and ↓ → slower phase 4 and slower conduction through AV node
- Ivabradine: directly inhibits HCN channels → ↓ → slows SA node without affecting contractility much
First, lock in the mental model: pacemaker vs ventricular action potentials
Pacemaker (SA/AV node) action potential
| Phase | Main current | What’s happening |
|---|---|---|
| 4 | (Na in) + T-type Ca | Spontaneous depolarization (“automaticity”) |
| 0 | L-type Ca in () | Upstroke (NOT fast Na) |
| 3 | K out | Repolarization |
Ventricular myocyte (non-pacemaker) action potential
| Phase | Main current | Clinical associations |
|---|---|---|
| 0 | Fast Na in () | Conduction velocity in working myocardium |
| 1 | Transient K out | “Notch” |
| 2 | Ca plateau ( in) balanced by K out | Contractility; Class IV drugs affect this |
| 3 | K out (e.g., ) | Repolarization; QT interval |
| 4 | maintains resting potential | Stable resting membrane potential |
Now, why each distractor is wrong (and what it really points to)
A. Fast inward sodium current () — Wrong cell type
Why it’s tempting: “Phase 0 depolarization = sodium influx,” right?
Why it’s wrong here: That’s true for atrial/ventricular myocytes and Purkinje fibers, not the SA node. Pacemaker cells have no fast Na upstroke; their phase 0 is Ca-mediated.
What actually tests:
- Conduction velocity in non-nodal tissue (phase 0 slope)
- Class I antiarrhythmics (Na channel blockers) widen QRS, slow conduction
High-yield hook:
If a question says “decreased upstroke velocity in ventricular myocytes” → think ↓ (Class I drugs, hyperkalemia, ischemia).
B. L-type calcium current () — Affects phase 0 (nodal) and plateau (ventricular), not phase 4 slope
Why it’s tempting: Nodal cells use Ca channels; slowing HR involves calcium…
Why it’s wrong: The question specifically asks about decreasing the slope of phase 4. is mainly responsible for:
- Phase 0 upstroke in SA/AV node
- Phase 2 plateau in ventricular myocytes
What actually tests:
- Non-dihydropyridine CCBs (verapamil, diltiazem):
- ↓ in AV node → slower conduction, ↑PR interval
- Can cause bradycardia, AV block
- Ventricular myocardium: ↓Ca influx → ↓contractility
High-yield distinction:
- SA node rate: mostly phase 4 slope ()
- AV node conduction: phase 0 Ca upstroke () → PR interval changes
D. Rapid delayed rectifier potassium current () — QT prolongation territory
Why it’s tempting: K currents = repolarization = rhythm changes.
Why it’s wrong: is about phase 3 repolarization in ventricular myocytes, not the SA node’s phase 4 automaticity.
What actually tests:
- Blockade of → prolonged repolarization → increased QT interval
- Risk of torsades de pointes
Classic associations:
- Class III antiarrhythmics (e.g., dofetilide, sotalol, amiodarone*) prolong QT
- Many non-cardiac drugs also block : macrolides, fluoroquinolones, antipsychotics, methadone, etc.
*Amiodarone prolongs QT but is less torsadogenic than others (still testable nuance).
High-yield rule:
If the stem says torsades or QT prolongation, scan for blockade.
E. Inward rectifier potassium current () — Locks in the resting potential of ventricular myocytes
Why it’s tempting: “Phase 4” shows up in both pacemaker and ventricular diagrams.
Why it’s wrong: In ventricular myocytes, phase 4 is flat because keeps the resting membrane potential stable. But in the SA node, there is no true stable resting potential—and is not the driver of automaticity.
What actually tests:
- Stabilizes resting membrane potential near the K equilibrium potential in working myocardium
- Altered by extracellular K changes (e.g., hyperkalemia makes resting potential less negative)
High-yield nuance:
When extracellular K rises enough, cells become partially depolarized → Na channels inactivate → slowed conduction, arrhythmias (a frequent exam trap).
The “one-liner” takeaways (memorize these)
- SA/AV node phase 4 slope = (HCN; increased by cAMP/β1; decreased by M2, beta-blockers, ivabradine)
- SA/AV node phase 0 upstroke = (targeted by verapamil/diltiazem; affects PR)
- Ventricular phase 0 = (Class I antiarrhythmics; QRS)
- Ventricular phase 3/QT = (Class III drugs; torsades risk)
- Ventricular phase 4 stability =
Rapid ECG correlation table (because Q-banks love this)
| What changes? | Most likely physiology | Common drug class |
|---|---|---|
| ↑PR interval | Slower AV nodal conduction (↓) | Non-DHP CCBs, beta-blockers |
| ↑QRS duration | Slower ventricular depolarization (↓) | Class I antiarrhythmics |
| ↑QT interval | Prolonged ventricular repolarization (↓) | Class III antiarrhythmics, many others |
| ↓HR (sinus bradycardia) | Reduced SA node automaticity (↓phase 4 slope, ↓) | Beta-blockers, ivabradine |
Final exam strategy: “Name the cell before you name the ion”
When a question asks about phase 4 slope, your first move is to decide:
- Pacemaker cell? → phase 4 is the automaticity ramp → think
- Ventricular myocyte? → phase 4 is the resting line → think
That single decision eliminates half the distractors before you even touch the answer choices.